IPR2016-00172 (Coherus BioSciences Inc.) (U.S. Patent No. 8,889,135)
- Petitioner: Coherus BioSciences Inc.
- Patent: U.S. Patent No. 8,889,135
- Patent Title: Methods of administering anti-TNF-α antibodies
- Patent Owner: AbbVie Biotechnology Ltd.
IPR2016-00172 (Coherus BioSciences Inc.) (U.S. Patent No. 8,889,135)
Comments are closed.